Answers are grounded in this paper and cite their sources.
Chronic myelogenous leukemia (LML) was recognized as a distinct entity in the mid-1800s. Since Nowell and Hunagerford initiated their research on CML in1960 our understanding in CML has been increasing. Imatinib became the preferred treatment from 2000 onwards as a result of its unprecedented success. The lack of structured Indian data on CML led to the formation of a CML data cansortuim which invited CML data albiet retro spartive form around the country including major cancer service providers both government and private. We provide a summary of published Indian data on CML here.
No takes yet. Share an insight, caveat, or question.
Singhal et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: